REGISTERED
on 16 Mar 2021
Last Applicant/ Owned by
Tour CBX, 1 passerelle des Reflets
Courbevoie
FR
92400
Serial Number
88980439 filed on 20th Aug 2019
Registration Number
6297099 registered on 16th Mar 2021
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
VOLLURE
Pharmaceutical preparations for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; biological dermal implants, namely, visco-supplementation solutions for filling wrinkles Apparatus, namely, injection needles and medical syringes for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; biological dermal implants, namely, visco-supplementation solutions for filling wrinkles
First Use Date in General
18th Mar 2020
First Use Date in Commerce
18th Mar 2020
Class [010]
Medical Instrument Products
Apparatus, namely, injection needles and medical syringes for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin
First Use Date in General
18th Mar 2020
First Use Date in Commerce
18th Mar 2020
Mark Details
Serial Number
No 88980439
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 16th Mar 2021 | REGISTERED-PRINCIPAL REGISTER |
| 11th Feb 2021 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 10th Feb 2021 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 04th Feb 2021 | STATEMENT OF USE PROCESSING COMPLETE |
| 04th Feb 2021 | DIVISIONAL PROCESSING COMPLETE |
| 01st Feb 2021 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 11th Jan 2021 | USE AMENDMENT FILED |
| 11th Jan 2021 | TEAS REQUEST TO DIVIDE RECEIVED |
| 11th Jan 2021 | TEAS STATEMENT OF USE RECEIVED |
| 22nd Dec 2020 | DIVISIONAL REQUEST RECEIVED |